Yuhan Corporation Renews Three Rapicol Cold Medicines

[Financial News] Yuhan Corporation has renewed its Rapicol line of over-the-counter cold medicines.
Yuhan Corporation announced on the 1st that it had launched three products—Rapicol Power Cold, Rapicol Power Cough and Rapicol Power Nose—which are renewed versions of the existing Rapicol Cold, Rapicol Cough Plus and Rapicol Nose, respectively.
All three products are liquid-filled soft capsules, a formulation designed to improve the speed and rate of drug absorption compared with standard tablets.
The amount of Acetaminophen, an antipyretic and analgesic ingredient, has been increased from 200 mg to 250 mg per capsule. For adults, taking two capsules three times a day results in a total daily intake of 1,500 mg.
Rapicol Power Cold and Rapicol Power Cough contain an additional 2 mg of Bromhexine hydrochloride alongside the existing expectorant ingredient Guaifenesin. Bromhexine helps thin phlegm, while Guaifenesin helps expel it.
The package size has also been increased from 10 capsules to 12. The products are intended for adults taking six capsules a day, so 12 capsules provide a two-day supply.
A Yuhan Corporation official said, "This renewal focused on strengthening the active ingredients in the existing Rapicol products and improving ease of use by increasing the package size to 12 capsules, equivalent to a two-day supply for adults." The official added, "We will continue to enhance the competitiveness of our over-the-counter products by reflecting feedback from consumers and pharmacies."

[email protected] Jung Sang-hee Reporter